News SciVision Biotech Inc.

Equities

1786

TW0001786002

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
108 ^TWD	-1.37%		+0.47%	+39.18%

Apr. 10	SciVision Biotech Inc.?s Products, Flexotron Solo (2.2%) and Flexotron Magnum (3%) Obtain Medical Device Licenses	CI
Apr. 09	Scivision Biotech Inc.'s CREATEFILL Obtains Medical Device License of Class III Medical Devices	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

SciVision Biotech Inc.?s Products, Flexotron Solo (2.2%) and Flexotron Magnum (3%) Obtain Medical Device Licenses	Apr. 10	CI
Scivision Biotech Inc.'s CREATEFILL Obtains Medical Device License of Class III Medical Devices	Apr. 09	CI
SciVision Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
SciVision Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
SciVision Biotech Inc.(TWSE:1786) added to S&P Global BMI Index	23-09-18	CI
SciVision Biotech Inc.'s Product, Cross-Linked Hyaluronic Acid Synovial Fluid Supplement ?Hyajoint Plus? Obtains Medical Device License	23-09-05	CI
SciVision Biotech Inc. Announces Corporate Governance Officer Changes	23-08-10	CI
SciVision Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
SciVision Biotech Inc. Approves Cash Dividend, Payable on August 18, 2023	23-06-28	CI
SciVision Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
SciVision Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-03	CI
SciVision Biotech Inc.(TWSE:1786) dropped from S&P Global BMI Index	22-09-19	CI
SciVision Biotech : Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds	22-08-15	PU
SciVision Biotech : Announcement of the approval for recordation being granted by FSC on extended offering period of the second domestic unsecured convertible bonds For 3 Months	22-08-11	PU
SciVision Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-03	CI
SciVision Biotech : Announcement of board meeting approved the consolidated financial statements for the second quarter of 2022	22-08-03	PU
SciVision Biotech : Announcement of the company's financial officer, accounting officer and corporate governance officer approved by Board of Directors.	22-06-29	PU
SciVision Biotech : Announce the record date for cash dividend	22-06-29	PU
SciVision Biotech : Announcement the Important Resolutions in 2022 Annual General Meeting of Shareholders	22-06-29	PU
SciVision Biotech Inc. Announces Cash Dividend, Payable on August 18, 2022	22-06-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News SciVision Biotech Inc.

Equities

1786

TW0001786002

Summary

Filters